Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei

Hepato-Gastroenterology

Volumn 54, Issue 73, 2007, Pages 47-52

  Hsu, Kai Hsi ^a   Chou, Cheng Yang ^a   Chang, Yu Chung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Debulking surgery; Intraperitoneal hyperthermia; Pseudomyxoma peritonei

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL; SODIUM CHLORIDE;

ADULT; AGED; APPENDIX; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MUCINOUS CARCINOMA; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR RECURRENCE; UTERINE TUBE;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, MUCINOUS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 34047139313     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Werth R: Pseudomyxoma peritonei. Arch Gynakol 1884; 24:100-118.
2. Jackson SL, Fleming RA, Loggie BW: Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. Mod Pathol 2001; 14:664-671.
3. Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM: Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol 1999; 154:1849-1855.
4. Shin HJC, Sneige N: Epithelial cells and other cytologic features of pseudomyxoma peritonei in patients with ovarian and/or appendiceal mucinous neoplasms: a study of 12 patients including 5 men. Cancer 2000; 90:17-23.
5. Mann WJ, Wagner J, Chumas J, Chalas E: The management of pseudomyxoma peritonei. Cancer 1990; 66:1636-1640.
6. Hsieh SY, Chiu CT, Sheen IS, Lin DY, Wu CS: A clinical study on pseudomyxoma peritonei. J Gastroenterol & Hepatol 1995; 10:86-91.
7. Sulkin TV, O'Neill H, Amin AI, Moran B: CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 2002; 57:608-613.
8. Ronnett BM, Yan H, Kurman RJ: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92:85-91.
9. Wertheim I, Fleischhacker D, McLachlin CM, Rice LW, Berkowitz RS, Goff BA: Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 1994; 84:17-21.
10. Esquivel J, Sugarbaker PH: Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair. Eur J Surg Oncol 2001; 27:54-58.
11. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens JM, O'Brien PC, van Heerden JA: Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994; 219:112-119.
12. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA: Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001; 88:458-463.
13. Cavaliere R, Ciocatto EC, Giovanella BC: Selective heat sensitivity and clinical studies. Cancer 1967; 20:1351-1381.
14. Falk MH, Issels RD: Hyperthermia in oncology. Int J Hyperthermia 2001; 17:1-18.
15. Huang HC, Huang YS, Shyr YM, Yen SH, Chang FY, Lee SD: Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival. Hepatogastroenterology 2002; 49:999-1001.
16. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A: Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1992; 70:396-401.
17. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995; 221:29-42.
18. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6:727-731.
19. Butterworth SA, Panton ON, Klaassen DJ, Shah AM, McGregor GI: Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei. Am J Surg 2002; 183:529-532.
20. Overgaard J: Effect of hyperthermia on malignant cells in vivo. Cancer 1977; 39:2637-2646.
21. Nishida T, Akagi K, Tanaka Y: Correlation between cell killing and cell membrane potential after heat treatment: analysis using fluorescent dye and flow cytometry. Int J Hyperthermia 1997; 13:227-234.
22. Overgaard J: Ultrastructure of a murine mammary carcinoma exposed to hyperthermia in vivo. Cancer Res 1976; 36:983-995.
23. Eddy HA: Alterations in tumor microvascular hyperthermia. Radiology 1980; 137:515-521.
24. Bicher HI, Hetzel FW, Sandhu TS: Effect of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137:523-530.
25. Sapareto SA, Dewey WC: Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10:787-800.
26. Fujimoto T, Takahashi M, Kikuchi S: Hyperthermia-induced antitumor activity in human gastric cancer cells serially transplanted into nude mice. Anticancer Res 1994; 14:67-71.
27. Spratt JS, Adcock RA, Muskovin M, et al: Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980; 40:256-260.
28. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH: Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetics studies. Oncology 1998; 55:130-138.